U.S. regulators approve Wegovy pill for weight loss – NPR
Lead: On Dec. 23, 2025, the U.S. Food and Drug Administration approved a daily oral form of Wegovy, marking the first pill approved to treat obesity in the United States. The pill, containing 25 mg of semaglutide, joins injectable GLP-1 drugs and is expected to appear in pharmacies within weeks. Regulators said the approval gives … Read more